Records containing: Metastatic Malignant Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-06A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
-
CLINICAL_TRIALS study record update · 2026-04-15Perception of Supportive Care Patients and Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center Regarding the Preference of Room Setting and Waiting Time
-
CLINICAL_TRIALS study record update · 2026-04-15A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-04-15Frequency and Correlates of Financial Distress in Advanced Cancer Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-09A Prospective Phase III Randomized Trial to Compare Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy for >/= 4 Newly Diagnosed Non-Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2026-02-17Cryoablation Challenge Evaluated in Adaptive-Immune Resistance (CEDAR)
-
CLINICAL_TRIALS study record update · 2026-02-17Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer: Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)
-
CLINICAL_TRIALS study record update · 2026-01-02Phase II Study of the PARP Inhibitor Talazoparib in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)
-
CLINICAL_TRIALS study record update · 2025-12-26Strategies for Persistent Agitated Delirium in Palliative Care
-
CLINICAL_TRIALS study record update · 2025-10-27A Phase 1 Trial of Vandetanib (a Multi-Kinase Inhibitor of EGFR, VEGFR, and RET Inhibitor) in Combination With Everolimus (an mTOR Inhibitor) in Advanced Cancer
-
CLINICAL_TRIALS study record update · 2025-06-27A Phase 1a/1b Dose Escalation and Dose Expansion Study of NPX887 in Participants With Solid Tumor Malignancies Known to Express B7-H7/HHLA2
-
CLINICAL_TRIALS study record update · 2025-06-27A Phase 1a/1b, Dose-Escalation/Dose-Expansion Study of NPX267 in Subjects With Solid Tumors Known to Express HHLA2/B7-H7
-
CLINICAL_TRIALS study record update · 2025-05-28A Phase II, Open-Label, Single-Arm, Multi-Cohort, Proof-of-Principle Study to Investigate the Efficacy of Cobimetinib and Atezolizumab in Advanced Rare Tumors
-
CLINICAL_TRIALS study record update · 2025-04-25A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)
-
CLINICAL_TRIALS study record update · 2024-09-19Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #2)
-
CLINICAL_TRIALS study record update · 2024-07-09A Phase 2, Open-Label Study to Evaluate Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic Human Papilloma Virus Associated Cancers
-
CLINICAL_TRIALS study record update · 2024-06-25A Pilot Study on the Efficacy of Advanced 18F-FDG PET-MRI in Spine Stereotactic Radiosurgery
-
CLINICAL_TRIALS study record update · 2023-08-04Pilot Study of Adoptive Cell Transfer for the Treatment of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes
-
CLINICAL_TRIALS study record update · 2022-09-21Effects of Physical Activity Plus Short Course of Dexamethasone for Cancer-Related Fatigue in Advanced Cancer
-
CLINICAL_TRIALS study record update · 2022-09-01Haloperidol and/or Chlorpromazine for Refractory Agitated Delirium in the Palliative Care Unit
-
CLINICAL_TRIALS study record update · 2022-03-03Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
-
CLINICAL_TRIALS study record update · 2021-05-14Ride to Care - A Pilot Study to Investigate the Clinical and Quality of Life Benefit of Eliminating Transportation Barriers for Disadvantaged Cancer Patients Undergoing Ambulatory Palliative Radiotherapy
-
CLINICAL_TRIALS study record update · 2021-02-25A Phase I Trial of Anakinra (IL-1 Receptor Antagonist) or Denosumab (Anti-RANKL Monoclonal Antibody) in Combination With Everolimus (mTOR Inhibitor) in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2021-01-22A Phase I Trial of Sorafenib (CRAF, BRAF, KIT, RET, VEGFR, PDGFR Inhibitor) or Crizotinib (MET, ALK, ROS1 Inhibitor) in Combination With Vemurafenib (BRAF Inhibitor) in Patients With Advanced Malignancies